In VIvo CAR-T
In Vivo CAR-T Technology Poised to Expand Access and Indications
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-25-NI-07Aug 11, 2025
LOGIC GATES
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-03Mar 14, 2025
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10Mar 02, 2025
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16Feb 19, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26Feb 11, 2025
Clinical Trials
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
Carsgen Therapeutics
PR-02-25-NI-09Feb 11, 2025
Biopreservation
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Vitrafy
PAO-10-24-RTM-02Nov 04, 2024
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33Nov 01, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04Sep 05, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03Feb 23, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
Umoja Biopharma
PAO-12-022-CL-04Jan 03, 2023
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06Nov 11, 2022
CRISPR Research Innovation
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
Gladstone Institutes
PR-M08-22-05Aug 25, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03Aug 09, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06Jul 02, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04Jun 24, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17Mar 30, 2022
Immunotherapy Research
Genetically Engineered Dual Receptor T-cells: Double Trouble for Cancer Cells
Juntendo University
PR-M01-22-23Jan 31, 2022
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
Mike Nicholson, Ph.D.
Inceptor Bio
PAO-10-21-CL-14Oct 22, 2021
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
David Y. H. Chang, Ph.D.
WuXi Advanced Therapies
PAO-05-21-CL-05May 27, 2021